Recent Patents on CNS Drug Discovery (Discontinued)
Title:Patent Selections:
Volume: 8 Issue: 1
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on CNS Drug Discovery (Discontinued) 2013; 8 (1) . https://dx.doi.org/10.2174/1574889811308010008
DOI https://dx.doi.org/10.2174/1574889811308010008 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
8
Related Articles
-
Systemic Lupus Erythematosus: Correlation Between Immunodysregulation and Clinical Manifestations
Current Rheumatology Reviews Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)
Current Topics in Medicinal Chemistry Drug Delivery to CNS: Challenges and Opportunities with Emphasis on Biomaterials Based Drug Delivery Strategies
Current Pharmaceutical Design Recent Advances Using Phosphodiesterase 4 (PDE4) Inhibitors to Treat Inflammatory Disorders: Animal and Clinical Studies
Current Drug Therapy Persistent Clinical Response of Infliximab Therapy in Patients with Refractory Rheumatoid Arthritis, over a 3-Year Period
Current Clinical Pharmacology Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors
Letters in Drug Design & Discovery Synthesis and Biological Evaluation of Atorvastatin Derivatives as Novel HMG-CoA Reductase Inhibitors
Letters in Drug Design & Discovery Breastfeeding and Diabetes
Current Diabetes Reviews Relationship Between the Pharmacokinetics of Levosimendan and Its Effects on Cardiovascular System
Current Drug Metabolism Post-stroke Depression Therapy: Where are we now?
Current Neurovascular Research Amaranth: A Pseudo-Cereal with Nutraceutical Properties
Current Nutrition & Food Science Atrial Fibrillation in Heart Failure: An Innocent Bystander?
Current Cardiology Reviews Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells
MicroRNA The Role of Neopterin in Atherogenesis and Cardiovascular Risk Assessment
Current Medicinal Chemistry Inhibition of mTOR Signaling by Quercetin in Cancer Treatment and Prevention
Anti-Cancer Agents in Medicinal Chemistry Thiazolidinediones and Cardiovascular Risk — A Question of Balance
Current Cardiology Reviews Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Medical Devices for Telemedicine and Home Care Applications
Recent Patents on Biomedical Engineering (Discontinued)